WordNet

relating to or associated with the bronchi; "bronchial tubes"; "bronchial pneumonia"
any malignant tumor derived from epithelial tissue; one of the four major types of cancer

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 肺癌の危険因子、病理、および臨床症状の概要 overview of the risk factors pathology and clinical manifestations of lung cancer
2. 気管支神経内分泌（カルチノイド）腫瘍：疫学、危険因子、分類、組織学的検査、診断、および病期分類 bronchial neuroendocrine carcinoid tumors epidemiology risk factors classification histology diagnosis and staging
3. 肺悪性腫瘍の病理 pathology of lung malignancies
4. 気管支神経内分泌（カルチノイド）腫瘍：治療および予後 bronchial neuroendocrine carcinoid tumors treatment and prognosis
5. 成人における喀血の病因および評価 etiology and evaluation of hemoptysis in adults

Persistence of Bronchial Dysplasia Is Associated with Development of Invasive Squamous Cell Carcinoma.

Merrick DT1, Gao D2, Miller YE3, Keith RL3, Baron AE4, Feser W4, Kennedy TC5, Blatchford PJ2, Braudrick S4, Hirsch FR6, Heasley L7, Bunn PA Jr8, Franklin WA6.
Cancer prevention research (Philadelphia, Pa.).Cancer Prev Res (Phila).2016 Jan;9(1):96-104. doi: 10.1158/1940-6207.CAPR-15-0305. Epub 2015 Nov 5.
Bronchial dysplasia (BD), a presumed precursor of pulmonary squamous cell carcinoma (SCC), rarely progresses to invasive cancer. A high-risk cohort at the University of Colorado provided an opportunity to directly sample airway epithelium at mapped sites on successive bronchoscopies. We have hypothe
PMID 26542061

177Lu-Labeled Agents for Neuroendocrine Tumor Therapy and Bone Pain Palliation in Uruguay.

Balter H1, Victoria T, Mariella T, Javier G, Rodolfo F, Andrea P, Graciela R, Juan H, Eugenia de M, Patricia O.
Current radiopharmaceuticals.Curr Radiopharm.2016;9(1):85-93.
Lutetium-177 is an emerging radionuclide due its convenient chemical and nuclear properties. In this paper we describe the development and evaluation in Uruguay of the targeted 177Lu labelled radiopharmaceuticals EDTMP (for bone pain palliation) and DOTA-TATE (neuroendocrine tumors). We optimized th
PMID 25771367

ALK-rearranged squamous cell lung carcinoma responding to crizotinib: A missing link in the field of non-small cell lung cancer?

Vergne F1, Quéré G2, Andrieu-Key S3, Descourt R4, Quintin-Roué I5, Talagas M6, De Braekeleer M7, Marcorelles P8, Uguen A9.
Lung cancer (Amsterdam, Netherlands).Lung Cancer.2016 Jan;91:67-9. doi: 10.1016/j.lungcan.2015.11.010. Epub 2015 Nov 10.
ALK-rearrangements are mainly encountered in lung adenocarcinomas and allow treating patients with anti-ALK targeted therapy. ALK-rearranged squamous cell lung carcinomas are rare tumors that can also respond to anti-ALK-targeted therapy. Nevertheless, ALK screening is not always performed in patien
PMID 26603857

Detection and identification of oral anaerobes in intraoperative bronchial fluids of patients with pulmonary carcinoma

川野大悟
日本呼吸器外科学会雑誌 28(4), 505-508, 2014
… 右上葉気管支及び左舌区支の分岐異常を認め，3D-CTにて肺動脈の走行異常も認めた．手術を施行したところ，上区・舌区間は完全過分葉を認め，上大区域切除術を施行した．病理組織検査の結果，Squamous cell carcinoma，pT1aN0M0，stage IAであった．手術後18ヵ月現在，明らかな再発は認めていない．気管支分岐異常の頻度は0.4～0.6％といわれている．その多くが右上葉気管支の転位性分岐異常であり，左舌区支の転位性分岐異 …
NAID 130004495397